Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?

Spondyloarthritides

(2012) Xenofon Baraliakos et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Factors Influencing Therapists' Decision-Making in the Acceptance of New Technology Devices in Stroke Rehabilitation

(2011) Christine C. Chen et al.   AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION

Current therapeutic approaches to autoimmune chronic uveitis in children

(2010) Gabriele Simonini et al.   AUTOIMMUNITY REVIEWS

Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis

(2010) M Trachana et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab

(2009) María M. Katsicas et al.   CLINICAL RHEUMATOLOGY

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

(2008) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

(2008) G Horneff et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nl

(2008) F. H. M. Prince et al.   RHEUMATOLOGY

TNFα blockade in human diseases: An overview of efficacy and safety

(2007) Jan Lin et al.   CLINICAL IMMUNOLOGY